Laurion Capital Management LP Nuvation Bio Inc. Transaction History
Laurion Capital Management LP
- $3.86 Billion
- Q1 2025
A detailed history of Laurion Capital Management LP transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 9,871,077 shares of NUVB stock, worth $24.3 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
9,871,077
Previous 6,491,475
52.06%
Holding current value
$24.3 Million
Previous $17.3 Million
0.61%
% of portfolio
0.45%
Previous 0.33%
Shares
5 transactions
Others Institutions Holding NUVB
# of Institutions
169Shares Held
157MCall Options Held
4.6KPut Options Held
154K-
Decheng Capital LLC Menlo Park, CA26MShares$63.8 Million12.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$39.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$37.9 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$32.2 Million47.43% of portfolio
-
Octagon Capital Advisors LP New York, NY7.9MShares$19.4 Million4.63% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $534M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...